Laurie, we know that somewhere between 70 and 90% of non namenda patients who have MMSE scores >10 have improved test scores on bryostatin on multiple test and compassionate use patients. Can they do it yet again and for a longer period of time? Going to take awhile to find out. Another variable with this current trial is they are lengthening the namenda washout period. That's always been hypothesized to be an issue. Could make for even better results this go around.
News 
Market Data 
Discover 
